Literature DB >> 3649335

Activation of the plasma kallikrein-kinin system by Vibrio vulnificus protease.

N Miyoshi, S Miyoshi, K Sugiyama, Y Suzuki, H Furuta, S Shinoda.   

Abstract

Vibrio vulnificus protease enhanced hypodermic vascular permeability when injected into the dorsal skin of a guinea pig. Enhancement of permeability was observed within 2 min, and the permeability-enhancing reaction terminated at about 10 min postinjection. The permeability-enhancing reaction was greatly augmented by simultaneous injection of a kininase II inhibitor, whereas the reaction was inhibited by soybean trypsin inhibitor, a well-known inhibitor of plasma kallikrein. Furthermore, in vitro activation of plasma prekallikrein to kallikrein by V. vulnificus protease was observed. These results indicate that V. vulnificus protease enhances vascular permeability through activation of the plasma kallikrein-kinin system which generates bradykinin, factor in edema formation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3649335      PMCID: PMC260630          DOI: 10.1128/iai.55.8.1936-1939.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness.

Authors:  G C Smith; J R Merkel
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

2.  Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.

Authors:  K Matsumoto; T Yamamoto; R Kamata; H Maeda
Journal:  J Biochem       Date:  1984-09       Impact factor: 3.387

3.  A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs.

Authors:  R Kamata; T Yamamoto; K Matsumoto; H Maeda
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

4.  Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus.

Authors:  J H Bowdre; M D Poole; J D Oliver
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp.

Authors:  M D Poole; J D Oliver
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

6.  Purification and characterization of Vibrio vulnificus protease.

Authors:  N Miyoshi; C Shimizu; S Miyoshi; S Shinoda
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

7.  Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus.

Authors:  L D Gray; A S Kreger
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

8.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

9.  Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy.

Authors:  Y Uchida; K Tanaka; Y Harada; A Ueno; M Katori
Journal:  Inflammation       Date:  1983-06       Impact factor: 4.092

10.  Detection of extracellular toxin(s) produced by Vibrio vulnificus.

Authors:  A Kreger; D Lockwood
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

View more
  18 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 2.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

Review 3.  Bacterial extracellular zinc-containing metalloproteases.

Authors:  C C Häse; R A Finkelstein
Journal:  Microbiol Rev       Date:  1993-12

4.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Regulation of metalloprotease gene expression in Vibrio vulnificus by a Vibrio harveyi LuxR homologue.

Authors:  C P Shao; L I Hor
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

6.  Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.

Authors:  H Kaminishi; M Tanaka; T Cho; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 7.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Significant role of an exocellular protease in utilization of heme by Vibrio vulnificus.

Authors:  Y Nishina; S Miyoshi; A Nagase; S Shinoda
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

9.  Cloning of a metalloprotease gene involved in the virulence mechanism of Vibrio anguillarum.

Authors:  D L Milton; A Norqvist; H Wolf-Watz
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

10.  Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates.

Authors:  Gary P Richards; Alberto Nuñez
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.